Publicaciones en las que colabora con MIGUEL ÁNGEL LÓPEZ NEVOT (21)

2021

  1. HLA-DRB1 ∗ 16:01 and HLA-DQB1 ∗ 05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma

    Journal of Oncology, Vol. 2021

  2. Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis

    Journal of Oncology, Vol. 2021

2011

  1. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

    Immunogenetics, Vol. 63, Núm. 2, pp. 65-71

2007

  1. Analysis of HLA class I alterations in tumors: Choosing a strategy based on known patterns of underlying molecular mechanisms

    Tissue Antigens

  2. Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours

    Tissue Antigens, Vol. 69, Núm. 3, pp. 220-226

  3. MHC Class I Antigens and Immune Surveillance in Transformed Cells

    International Review of Cytology, Vol. 256, pp. 139-189

2006

  1. LOH at 6p21.3 region and HLA class altered phenotypes in bladder carcinomas

    Immunogenetics, Vol. 58, Núm. 7, pp. 503-510

2004

  1. Distribution of HLA class I altered phenotypes in colorectal carcinomas: High frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

    Immunogenetics, Vol. 56, Núm. 4, pp. 244-253

2003

  1. Analysis of HLA expression in human tumor tissues

    Cancer Immunology, Immunotherapy, Vol. 52, Núm. 1, pp. 1-9

  2. High frequency of HLA-B44 allelic losses in human solid tumors

    Human Immunology, Vol. 64, Núm. 10, pp. 941-950

2002

  1. Impaired surface antigen presentation in tumors: Implications for T cell-based immunotherapy

    Seminars in Cancer Biology, Vol. 12, Núm. 1, pp. 15-24

  2. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: High frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

    Cancer Immunology, Immunotherapy, Vol. 51, Núm. 7, pp. 389-396

2001

  1. A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-a*0301 allele in a prostate carcinoma cell line

    Immunogenetics, Vol. 53, Núm. 7, pp. 606-610

  2. Loss of HLA-B44 and type II altered HLA phenotype in human tumors

    European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 327

2000

  1. Molecular strategies to define HLA haplotype loss in microdissected tumor cells

    Human Immunology, Vol. 61, Núm. 10, pp. 1001-1012

  2. β2-Microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors

    International Journal of Clinical and Laboratory Research, Vol. 30, Núm. 2, pp. 87-92

1998

  1. Mutations of the β2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

    Tissue Antigens, Vol. 52, Núm. 6, pp. 520-529

1995

  1. Hla Class I Antigens in Human Tumors

    Advances in Cancer Research, Vol. 67, Núm. C, pp. 155-195

1990

  1. Class II HLA Antigen Expression in Familial Polyposis Coli is Related to the Degree of Dysplasia

    Immunobiology, Vol. 180, Núm. 2-3, pp. 138-148

1987

  1. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: Relation with malignancy and invasiveness

    Experimental and Clinical Immunogenetics, Vol. 4, Núm. 3, pp. 144-152